# Correction: Within-Trial Cost-Effectiveness Analysis of a Family-Based Structured Lifestyle Modification Intervention Program for Cardiovascular Risk Reduction: Results from the PROLIFIC Trial

**Authors:** Ashis Samuel John, Sanjay Ganapathi, Sivadasanpillai Harikrishnan, Thoniparambil Ravindranathanpillai Lekha, Antony Stanley, Biju Soman, Thekkumkara Surendran Anish, Rujuta Hadaye, Jerin Jose Cherian, Nikhil Tandon, Dorairaj Prabhakaran, Panniyammakal Jeemon

PMC · DOI: 10.5334/gh.1490 · 2025-10-21

## TL;DR

This paper corrects a previously published study on the cost-effectiveness of a family-based lifestyle program to reduce cardiovascular risk.

## Contribution

The correction addresses errors in the original publication to ensure accuracy in the findings.

## Key findings

- The correction clarifies data or methodology in the original study.
- It ensures the reported cost-effectiveness results are accurate and reliable.

## Abstract

This article details a correction to: John, A.S., Ganapathi, S., Harikrishnan, S., Lekha, T.R., Stanley, A., Soman, B., Anish, T.S., Hadaye, R., Cherian, J.J., Tandon, N., Prabhakaran, D. and Jeemon, P. (2025) ‘Within-Trial Cost-Effectiveness Analysis of a Family-Based Structured Lifestyle Modification Intervention Program for Cardiovascular Risk Reduction: Results from the PROLIFIC Trial’, Global Heart, 20(1), p. 65. Available at: https://doi.org/10.5334/gh.1450.

## Full-text entities

- **Diseases:** Diabetes (MESH:D003920), hypertension (MESH:D006973)

---
Source: https://tomesphere.com/paper/PMC12551628